<- Go Home

Mangoceuticals, Inc.

Mangoceuticals, Inc. develops, markets, and sells various men’s wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Market Cap

$6.3M

Volume

125.8K

Cash and Equivalents

$73.9K

EBITDA

-$8.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$442.4K

Profit Margin

58.60%

52 Week High

$16.80

52 Week Low

$2.10

Dividend

N/A

Price / Book Value

0.41

Price / Earnings

-0.45

Price / Tangible Book Value

-4.46

Enterprise Value

$6.5M

Enterprise Value / EBITDA

-0.78

Operating Income

-$8.5M

Return on Equity

126.52%

Return on Assets

-64.73

Cash and Short Term Investments

$73.9K

Debt

$269.0K

Equity

$13.4M

Revenue

$755.0K

Unlevered FCF

-$1.5M

Sector

Consumer Staples Distribution and Retail

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches